Company Filing History:
Years Active: 2013
Title: Innovations of Fumiya Hamano in Drug Release Technology
Introduction
Fumiya Hamano, an inventive mind based in Matsubara, Japan, has made significant contributions to the field of pharmaceutical technology. His work primarily focuses on the development of drug delivery systems that enhance efficacy and stability.
Latest Patents
Hamano holds a patent for "Sustained release micropellets and process for producing the same." This innovative solution addresses the need for stable controlled-release of drugs, irrespective of pH fluctuations. The patented process involves coating core particles with a layer of a water-soluble drug and subsequently applying a film layer made from a water-insoluble polymer compound and a plasticizer. Notably, a water-soluble filler layer is positioned between the drug-containing layer and the film layer, resulting in micropellets with an average particle size of 300 µm or less. His invention includes medicinal compositions comprising these micropellets and outlines the process for their production.
Career Highlights
Fumiya Hamano is affiliated with Fujimoto Co., Ltd., where he has played a vital role in advancing drug delivery technologies. His innovative approach and expertise have been instrumental in the company's research initiatives and product development, making significant strides in the pharmaceutical industry.
Collaborations
Hamano collaborates with esteemed colleagues such as Fumio Yoneda and Eisaku Kitano. Together, they contribute to the continued advancement of drug delivery systems and share insights that foster innovation within the company.
Conclusion
Fumiya Hamano’s contributions to the field of sustained drug release are noteworthy, particularly through his patented micropellet technology. His ongoing collaboration with fellow researchers further enhances the capabilities of Fujimoto Co., Ltd., positioning the company as a leader in innovative drug delivery solutions. With a focus on stability and efficiency, Hamano’s work continues to pave the way for advancements in medicine.